High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring.

Isabell Bernlochner; Katharina Mayer; Tanja Morath; Siegmund Braun; Stefanie Schulz; Albert Schömig; Werner Koch; Adnan Kastrati; Dirk Sibbing

doi:10.3109/09537104.2012.715218

High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring.

Identifier:nobleid.org/w1/20260515/17A08321

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/17A08321.svg?ark=w1%2F20260515%2F17A08321)](https://nobleid.org/work/w1/20260515/17A08321)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring.

Identifier:nobleid.org/w1/20260515/17A08321

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/17A08321.svg?ark=w1%2F20260515%2F17A08321)](https://nobleid.org/work/w1/20260515/17A08321)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work